How Can Predictive Biomarkers Improve Drug Safety?
In drug development, predictive biomarkers can identify potential safety issues before clinical trials, thereby preventing adverse drug reactions. They help in stratifying patients in clinical trials, ensuring that those who are more likely to benefit from a treatment or are at higher risk of side effects are identified early on. This not only enhances the safety profile of new drugs but also improves the drug development process by reducing costs and time.
